✦ LIBER ✦

A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults

✍ Scribed by JR Baldwin; JC Fleishaker; NE Azie; BJ Carel

Book ID: 111090994
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 235 KB
Volume: 24
Category: Article
ISSN: 0333-1024
DOI: 10.1111/j.1468-2982.2004.00673.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The tolerability and pharmacokinetics of

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

✍ E. SEABER; N. ON; S. PHILLIPS; R. CHURCHUS; J. POSNER; P. ROLAN 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Influence of gender on the pharmacokinet

Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

✍ J. Isaacsohn; M. Zinny; A. Mazzu; J. Lettieri; A.H. Heller 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 87 KB

Pharmacokinetics, safety, and tolerabili

Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults

✍ Pavliv, L.; Voss, B.; Rock, A. 📂 Article 📅 2011 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 248 KB

T-705, A Novel Anti-Influenza Virus Comp

T-705, A Novel Anti-Influenza Virus Compound - the Safety, Tolerability and Pharmacokinetics in Human

✍ O. Kobayashi; M. Noto; T. Sakurai; A. Iwamoto 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Almotriptan and zolmitriptan in the acut

Almotriptan and zolmitriptan in the acute treatment of migraine

✍ P. J. Goadsby; H. Massiou; J. Pascual; H.-C. Diener; C. G. H. Dahlöf; V. Mateos; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

A review of the pharmacokinetics, tolera

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine